You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JANX Gift Disclosure
Campbell David Alan · SEC Form 4 · Filed Jul 31, 2026
Gift
Calculated transaction value
$0
Campbell David Alan President And CEO
JANX
Janux Therapeutics
JANX
Transaction date
Jul 31, 2026
Public filing date
Jul 31, 2026
Filing lag
Filed same day
JANX daily price context
Close on/before transaction
$15.17
Jul 31, 2026
First close after public filing
$15.32
Aug 3, 2026
30-day return after filing
+18.93%
Through Aug 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 123,840 shares @ $0
- SEC ownership
- Direct
- Transaction code
- G
- Form
- 4
- Filing identifier
- 0001864158-26-000006
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Janux Therapeutics, Inc. JANX Current | Gift | Jul 31, 2026 | $0 |